These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2645464)

  • 1. Continuous systemic 5-fluorouracil infusion in advanced colorectal cancer: results in 91 patients.
    Hansen R; Quebbeman E; Ausman R; Frick J; Ritch P; Schulte W; Haas C; Beatty P; Anderson T
    J Surg Oncol; 1989 Mar; 40(3):177-81. PubMed ID: 2645464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trial of continuous infusion of 5-fluorouracil using an ambulatory pump for metastatic colorectal cancer.
    Yamao T; Shimada Y; Kondo H; Shirao K; Yokota T; Sugano K; Saito D; Ohkura H; Yoshida S
    Jpn J Clin Oncol; 1995 Apr; 25(2):46-50. PubMed ID: 7745822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous infusion fluorouracil/leucovorin and bolus mitomycin-C as a salvage regimen for patients with advanced colorectal cancer.
    Conti JA; Kemeny NE; Saltz LB; André AM; Grossano DD; Bertino JR
    Cancer; 1995 Feb; 75(3):769-74. PubMed ID: 7828126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous 5-fluorouracil infusion in refractory carcinoma of the breast.
    Hansen R; Quebbeman E; Beatty P; Ritch P; Anderson T; Jenkins D; Frick J; Ausman R
    Breast Cancer Res Treat; 1987 Nov; 10(2):145-9. PubMed ID: 3427223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous systemic 5-fluorouracil infusion in refractory prostatic cancer.
    Hansen R; Moynihan T; Beatty P; Quebbeman E; Libnoch J; Schulte W; Anderson T
    Urology; 1991 Apr; 37(4):358-61. PubMed ID: 2014602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous 5-fluorouracil (5FU) infusion in carcinoma of the pancreas: a phase II study.
    Hansen R; Quebbeman E; Ritch P; Chitambar C; Anderson T
    Am J Med Sci; 1988 Feb; 295(2):91-3. PubMed ID: 3344760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged continuous infusion of fluorouracil with weekly bolus leucovorin: a phase II study in patients with disseminated colorectal cancer.
    Leichman CG; Leichman L; Spears CP; Rosen PJ; Jeffers S; Groshen S
    J Natl Cancer Inst; 1993 Jan; 85(1):41-4. PubMed ID: 8416255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer.
    Hansen RM; Ryan L; Anderson T; Krzywda B; Quebbeman E; Benson A; Haller DG; Tormey DC
    J Natl Cancer Inst; 1996 May; 88(10):668-74. PubMed ID: 8627643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer.
    Lévi F; Misset JL; Brienza S; Adam R; Metzger G; Itzakhi M; Caussanel JP; Kunstlinger F; Lecouturier S; Descorps-Declère A
    Cancer; 1992 Feb; 69(4):893-900. PubMed ID: 1735081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of advanced colorectal cancer with long-term continuous infusion of 5-fluorouracil].
    Kotake K; Koyama Y; Nasu J; Ando J; Ozawa I; Ogata Y
    Gan To Kagaku Ryoho; 1994 Jan; 21(1):47-52. PubMed ID: 8291915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of refractory metastatic breast cancer with 5-fluorouracil and levofolinic acid as 48 hours continuous venous infusion.
    Gebbia V; Mauceri G; Testa A; Tirrito M; Varvara F; Cucchiara A; Borsellino N; Girlando A; Ferrara M; Caruso F
    Anticancer Res; 1999; 19(3B):2289-92. PubMed ID: 10472346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged 5-fluorouracil infusion in patients with metastatic colon cancer pretreated with bolus schedule of the same agent.
    Tralongo P; Di Mari A; Scibilia G; Bosco V; Giudice A; Respini D; Failla G
    Anticancer Res; 1995; 15(2):635-8. PubMed ID: 7539242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer.
    Buroker TR; O'Connell MJ; Wieand HS; Krook JE; Gerstner JB; Mailliard JA; Schaefer PL; Levitt R; Kardinal CG; Gesme DH
    J Clin Oncol; 1994 Jan; 12(1):14-20. PubMed ID: 7677801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5-fluorouracil: a phase II study in pretreated patients with metastatic colorectal cancer.
    Comella P; Massidda B; Palmeri S; Putzu C; De Rosa V; Izzo F; Fiore F; Casaretti R; Sandomenico C
    Anticancer Drugs; 2006 Sep; 17(8):985-92. PubMed ID: 16940809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients.
    Guglielmi A; Aschele C; Grossi F; Tixi L; Sobrero A
    Cytotechnology; 1996; 19(3):215-9. PubMed ID: 8862009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study.
    Carlomagno C; Lauria R; De Laurentiis M; Arpino G; Massarelli E; Ferrara C; Milano A; Vernaglia Lombardi A; Costanzo R; Catalano G; Bianco AR; De Placido S
    Oncology; 2002; 63(3):219-25. PubMed ID: 12381900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II study.
    Hartmann JT; Köhne CH; Schmoll HJ; Daikeler T; Kanz L; Bokemeyer C
    Oncology; 1998; 55(4):320-5. PubMed ID: 9663421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer.
    Hochster H; Chachoua A; Speyer J; Escalon J; Zeleniuch-Jacquotte A; Muggia F
    J Clin Oncol; 2003 Jul; 21(14):2703-7. PubMed ID: 12860947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose folinic acid and 5-fluorouracil bolus and continuous infusion for patients with advanced colorectal cancer.
    Bécouarn YH; Brunet RC; Rouhier ML; Bussières EJ; Avril AR; Richaud PM; Dilhuydy JM
    Cancer; 1995 Oct; 76(7):1126-31. PubMed ID: 8630887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.